Differential Estimation of CKD Using Creatinine- Versus Cystatin C-Based Estimating Equations by Category of Body Mass Index

American Journal of Kidney Diseases

Volumn 53, Issue 6, 2009, Pages 993-1001

  Vupputuri, Suma ^a   Fox, Caroline S ^b,c   Coresh, Josef ^d   Woodward, Mark ^e   Muntner, Paul ^e  

^a Center for Health Research   (United States)

^b FRAMINGHAM HEART STUDY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

body mass index; Chronic kidney insufficiency; creatinine; cystatin C; glomerular filtration rate

Indexed keywords

CREATININE; CYSTATIN C;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHILD; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RACE DIFFERENCE; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CHILD; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREVALENCE; YOUNG ADULT;

EID: 67349114859     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.12.043     Document Type: Article

References (32)

1. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
2. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
3. Rule A.D., Larson T.S., Bergstralh E.J., Slezak J.M., Jacobsen S.J., and Cosio F.G. Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med 141 (2004) 929-937
4. Rule A.D., Bergstralh E.J., Slezak J.M., Bergert J., and Larson T.S. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 69 (2006) 399-405
5. Laterza O.F., Price C.P., and Scott M.G. Cystatin C: An improved estimator of glomerular filtration rate?. Clin Chem 48 (2002) 699-707
6. Dharnidharka V.R., Kwon C., and Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 40 (2002) 221-226
7. Stevens L.A., Coresh J., Schmid C.H., et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51 (2008) 395-406
8. Levin A., and Stevens L.A. Executing change in the management of chronic kidney disease: Perspectives on guidelines and practice. Med Clin North Am 89 (2005) 701-709
9. Madero M., Sarnak M.J., and Stevens L.A. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens 15 (2006) 610-616
10. Fried L.F., Lee J.S., Shlipak M., et al. Chronic kidney disease and functional limitation in older people: Health, Aging and Body Composition Study. J Am Geriatr Soc 54 (2006) 750-756
11. Knight E.L., Verhave J.C., Spiegelman D., et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65 (2004) 1416-1421
12. Kottgen A., Selvin E., Stevens L.A., Levey A.S., Van Lente F., and Coresh J. Serum cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 51 (2008) 385-394
13. Muntner P., Winston J., Uribarri J., Mann D., and Fox C.S. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med 121 (2008) 341-348
14. Stevens L.A., Greene T., Li C., et al. Factors other than GFR influencing serum cystatin. J Am Soc Nephrol 18 (2007) 547A-548A (abstr)
15. Kratchmarova I., Kalume D.E., Blagoev B., et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 1 (2002) 213-222
16. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994, vol 1994:1. Publication 94-1308 (1994), US Department of Health and Human Services, Washington, DC
17. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
18. Coresh J., Astor B.C., McQuillan G., et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39 (2002) 920-929
19. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
20. Kalantar-Zadeh K., Block G., Humphreys M.H., and Kopple J.D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63 (2003) 793-808
21. Filler G., Bokenkamp A., Hofmann W., Le Bricon T., Martinez-Bru C., and Grubb A. Cystatin C as a marker of GFR-History, indications, and future research. Clin Biochem 38 (2005) 1-8
22. Jones C.Y., Jones C.A., Wilson I.B., et al. Cystatin C and creatinine in an HIV cohort: The Nutrition for Healthy Living Study. Am J Kidney Dis 51 (2008) 914-924
23. Bokenkamp A., Domanetzki M., Zinck R., Schumann G., Byrd D., and Brodehl J. Cystatin C-A new marker of glomerular filtration rate in children independent of age and height. Pediatrics 101 (1998) 875-881
24. Shlipak M.G., Sarnak M.J., Katz R., et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352 (2005) 2049-2060
25. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
26. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J Clin Invest 106 (2000) 473-481
27. MacDougald O.A., and Mandrup S. Adipogenesis: Forces that tip the scales. Trends Endocrinol Metab 13 (2002) 5-11
28. Taleb S., Cancello R., Clement K., and Lacasa D. Cathepsin S promotes human preadipocyte differentiation: Possible involvement of fibronectin degradation. Endocrinology 147 (2006) 4950-4959
29. Taleb S., Lacasa D., Bastard J.P., et al. Cathepsin S, a novel biomarker of adiposity: Relevance to atherogenesis. FASEB J 19 (2005) 1540-1542
30. Young J.A., Hwang S.J., Sarnak M.J., et al. Association of visceral and subcutaneous adiposity with kidney function. Clin J Am Soc Nephrol 3 (2008) 1786-1791
31. Ogden C.L., Carroll M.D., McDowell M.A., and Flegal K.M. Obesity Among Adults in the United States-No Change Since 2003-2004. NCHS Data Brief no. 1 (2007), National Center for Health Statistics, Hyattsville, MD
32. Myers G.L., Miller W.G., Coresh J., et al. Recommendations for improving serum creatinine measurement: A report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52 (2006) 5-18